Deconinck, Eric <br/><br/>
Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation.  [electronic resource] 

 -  PharmacoEconomics  2010 
 - 35-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2027 
<br/><br/><label>Standard No.: </label>10.2165/11314070-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--economics<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--economics<br/>Cost-Benefit Analysis<br/>Drug Resistance, Neoplasm<br/>France<br/>Humans<br/>Long-Term Care<br/>Lymphoma, Follicular--drug therapy<br/>Markov Chains<br/>National Health Programs<br/>Quality-Adjusted Life Years<br/>Recurrence<br/>Rituximab